Wagend Infra (503675)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at ₹1.27 versus book value of ₹2.08, a 39% discount to stated assets
• Market cap of ₹6 Cr leaves limited downside if assets hold their stated value
• Latest quarter still shows sales of ₹1 Cr, indicating some operational life
• ROCE is positive at 0.32%, suggesting capital is not completely idle

Concerns

• Net profit is ₹0 Cr and profit growth is -100%, so the P/E is meaningless
• ROE at -0.97% means the company is eroding book value
• Piotroski F-Score of 3/9 signals weak financial health
• No dividend, no sales growth, and no promoter holding or debt visibility raise governance and balance-sheet red flags

AI Analysis

At ₹1.27, Wagend Infra has a market cap of just ₹6 Cr against a book value of ₹2.08 per share, so it trades at 0.61 times book. That looks like Graham's discount-to-assets bargain. But a bargain only counts if the assets can earn a return. The latest quarter shows sales of ₹1 Cr and net profit of ₹0 Cr. ROE is -0.97%, ROCE is only 0.32%, and profit growth is -100%. The P/E is meaningless because there are no real earnings. Piotroski F-Score of 3/9 reinforces weak financial health. There is no dividend, no sales growth, and promoter holding is not disclosed. This is a business that is merely existing, not compounding. Buffett would say it is far better to buy a wonderful business at a fair price than a poor business at a wonderful price. The only apparent edge is the 39% discount to stated book value. But with negative ROE, the book value cushion can erode over time. Graham would demand a margin of safety in earnings power, not just assets. For an Indian retail investor, this looks like an asset play with no active engine — possibly a value trap unless something changes. I would need evidence of a genuine turnaround: positive net profit, rising sales, an improved F-score, and clear promoter commitment. Until then, the numbers say wait.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer